Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 121

Results For "report"

1829 News Found

Concord Biotech gets SEBI nod for IPO
News | December 07, 2022

Concord Biotech gets SEBI nod for IPO

The IPO is a complete OFS by existing shareholder Helix Investment Holdings


SRL Diagnostics launches laboratory in Shimla
Clinical Trials | December 01, 2022

SRL Diagnostics launches laboratory in Shimla

The laboratory has the capacity to conduct 30,000+ tests in a month ranging from simple routine tests to semi-specialized and specialized tests


Philips advances AI-powered diagnostic systems and transformative workflow solutions
Digitisation | November 28, 2022

Philips advances AI-powered diagnostic systems and transformative workflow solutions

Latest innovations feature vendor-neutral solutions to help reduce clinical complexity and enhance operational efficiency


Centre deploys three teams to manage high measles cases among children
News | November 24, 2022

Centre deploys three teams to manage high measles cases among children

The teams will assist the state health authorities in instituting public health measures and facilitate operationalization of requisite control and containment measures


Vivimed Labs Q2 FY2023 consolidated loss at Rs. 22.03 Cr
News | November 19, 2022

Vivimed Labs Q2 FY2023 consolidated loss at Rs. 22.03 Cr

The company has reported total income of Rs. 44.37 crores during the period ended September 30, 2022


Strand Life Sciences launches ‘Strand Genomic Wellness’
Biotech | November 18, 2022

Strand Life Sciences launches ‘Strand Genomic Wellness’

Strand’s new offering will help people better understand and manage diseases through genomic sequencing


IOL Chemicals and Pharmaceuticals Q2FY23 net profit drops to Rs 15.6 Cr
News | November 15, 2022

IOL Chemicals and Pharmaceuticals Q2FY23 net profit drops to Rs 15.6 Cr

The company registered with REACH Certificate for Ethyl Acetate with a tonnage band of more than 1000 TPA


Suven Life Sciences posts Q2FY23 consolidated loss at Rs. 23.18 Cr
News | November 14, 2022

Suven Life Sciences posts Q2FY23 consolidated loss at Rs. 23.18 Cr

The company has reported total income of Rs. 4.59 crores during the period ended September 30, 2022


Supriya Lifescience Q2 FY2023 profit slips to Rs. 16.86 Cr
News | November 14, 2022

Supriya Lifescience Q2 FY2023 profit slips to Rs. 16.86 Cr

The company has reported total income of Rs. 114.77 crores during the period ended September 30, 2022.